Nathalie Laarakker
Director/Board Member at OXURION NV
Nathalie Laarakker active positions
Companies | Position | Start | End |
---|---|---|---|
OXURION NV | Director/Board Member | 2023-05-01 | - |
Independent Dir/Board Member | 2023-05-01 | - | |
Intravacc BV | Director/Board Member | 2021-03-31 | - |
Director of Finance/CFO | 2021-03-31 | - |
Career history of Nathalie Laarakker
Former positions of Nathalie Laarakker
Companies | Position | Start | End |
---|---|---|---|
MERUS N.V. | Corporate Officer/Principal | - | - |
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | 2017-12-31 | - |
Training of Nathalie Laarakker
University of Amsterdam | Undergraduate Degree |
Statistics
International
Netherlands | 5 |
Belgium | 2 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
OXURION NV | Health Technology |
MERUS N.V. | Health Technology |
Private companies | 2 |
---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
Intravacc BV | Health Technology |
- Stock Market
- Insiders
- Nathalie Laarakker
- Experience